Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201/KEYNOTE-942 trial

被引：0

作者：

Khattak, Adnan

Weber, Jeffrey S.

Meniawy, Tarek

Taylor, Matthew H.

Ansstas, George

Kim, Kevin B.

McKean, Meredith

Long, Georgina V.

Sullivan, Ryan J.

Faries, Mark B.

Tran, Thuy

Cowey, Charles Lance

Medina, Theresa Michelle

Segar, Jennifer Margaret

Atkinson, Victoria

Gibney, Geoffrey Thomas

Luke, Jason J.

Buchbinder, Elizabeth Iannotti

Meehan, Robert S.

Carlino, Matteo S.

机构：

[1] One Clin Res, Perth, WA, Australia

[2] Edith Cowan Univ, Perth, WA, Australia

[3] NYU Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA

[4] Sir Charles Gairdner Hosp, Nedlands, WA, Australia

[5] Earle Chiles Res Inst, Portland, OR USA

[6] Washington Univ Oncol, St Louis, MO USA

[7] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA

[8] Sarah Cannon Res Inst, Tennessee Oncol, Nashville, TN USA

[9] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia

[10] Royal North Shore & Mater Hosp, Sydney, NSW, Australia

[11] Massachusetts Gen Hosp, Boston, MA USA

[12] Angeles Clin & Res Inst, Los Angeles, CA USA

[13] Yale New Haven Hosp, New Haven, CT USA

[14] Texas Oncol Baylor Charles Sammons Canc Ctr, Dallas, TX USA

[15] Univ Colorado, Aurora, CO USA

[16] Univ Arizona, Ctr Canc, Tucson, AZ USA

[17] Princess Alexandra Hosp, Woolloongabba, Qld, Australia

[18] Univ Queensland, Woolloongabba, Qld, Australia

[19] Lombardi Comprehens Canc Ctr, Washington, DC USA

[20] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[21] Dana Farber Canc Inst, Boston, MA USA

[22] Moderna Therapeut, Cambridge, MA USA

[23] Univ Sydney, Melanoma Inst Australia, Westmead & Blacktown Hosp, Sydney, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 17期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA9503

引用

页数：1

共 50 条

[31] Progression-free survival results in patient subgroups from a Phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON) [J].

Robertson, J. F. R. ;

Noguchi, S. ;

Shao, Z. ;

Grinsted, L. M. ;

Fazal, M. ;

Ellis, M. J. .

CANCER RESEARCH, 2017, 77

[32] Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial [J].

Rugo, Hope S. ;

Im, Seock-Ah ;

Cardoso, Fatima ;

Cortes, Javier ;

Curigliano, Giuseppe ;

Musolino, Antonino ;

Pegram, Mark D. ;

Bachelot, Thomas ;

Wright, Gail S. ;

Saura, Cristina ;

Escriva-de-Romani, Santiago ;

De Laurentiis, Michelino ;

Schwartz, Gary N. ;

Pluard, Timothy J. ;

Ricci, Francesco ;

Gwin II, William R. ;

Levy, Christelle ;

Brown-Glaberman, Ursa ;

Ferrero, Jean-Marc ;

de Boer, Maaike ;

Kim, Sung-Bae ;

Petrakova, Katarina ;

Yardley, Denise A. ;

Freedman, Orit ;

Jakobsen, Erik H. ;

Gal-Yam, Einav Nili ;

Yerushalmi, Rinat ;

Fasching, Peter A. ;

Kaufman, Peter A. ;

Ashley, Emily J. ;

Perez-Olle, Raul ;

Hong, Shengyan ;

Rosales, Minori Koshiji ;

Gradishar, William J. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :198-+

[33] METASTASIS-FREE SURVIVAL (MFS) IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS (PTS) WITH PROSTATE-SPECIFIC ANTIGEN (PSA) DECLINE TO < 0.2 NG/ML FOLLOWING APALUTAMIDE (APA) TREATMENT: POST HOC RESULTS FROM THE PHASE 3 SPARTAN STUDY [J].

Graff, Julie N. ;

Saad, Fred ;

Hadaschik, Boris A. ;

Mainwaring, Paul N. ;

Uemura, Hiroji ;

Chowdhury, Simon ;

Oudard, Stephane ;

Olmos, David ;

Lee, Ji Youl ;

Lopez-Gitlitz, Angela ;

Bhaumik, Amitabha ;

Londhe, Anil ;

Cheng, Shinta ;

Todd, Mary B. ;

Smith, Matthew R. ;

Small, Eric J. .

JOURNAL OF UROLOGY, 2019, 201 (04) :E503-E503

[34] A NOVEL FORMULATION OF CT-P13 FOR SUBCUTANEOUS ADMINISTRATION: 30 WEEK RESULTS FROM A PART 2 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH RHEUMATOID ARTHRITIS [J].

Westhovens, Rene ;

Wiland, Piotr ;

Zawadzki, Marek ;

Ivanova, Delina ;

Berrocal, Alfredo ;

Chalouhi, Elias ;

Balazs, Eva ;

Shevchuk, Sergii ;

Eliseeva, Larisa ;

Stanislavchuk, Mykola ;

Yatsyshyn, Roman ;

Lee, Sangjoon ;

Suh, Jeehye ;

Lee, Seulgi ;

Kim, Yunah ;

Yoo, Daehyun .

ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 :1158-1159

[35] Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/ GEJ) adenocarcinoma: Survival results from the phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study [J].

Janjigian, Y. Y. ;

Kawazoe, A. ;

Bai, Y. ;

Xu, J. ;

Lonardi, S. ;

Metges, J-P. ;

Weber, P. E. Yanez ;

Wyrwicz, L. S. ;

Shen, L. ;

Ostapenko, Y. V. ;

Bilici, M. ;

Chung, H. C. ;

Shitara, K. ;

Qin, S. ;

Van Cutsem, E. ;

Tabernero, J. ;

Li, K. ;

Shih, C-S. ;

Bhagia, P. ;

Rha, S. Y. .

ANNALS OF ONCOLOGY, 2023, 34 :S851-S852

[36] Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial [J].

Maria Vittoria Dieci ;

Giancarlo Bisagni ;

Stefania Bartolini ;

Antonio Frassoldati ;

Roberto Vicini ;

Sara Balduzzi ;

Roberto D’amico ;

Pierfranco Conte ;

Valentina Guarneri .

npj Breast Cancer, 9

[37] Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial [J].

Dieci, Maria Vittoria ;

Bisagni, Giancarlo ;

Bartolini, Stefania ;

Frassoldati, Antonio ;

Vicini, Roberto ;

Balduzzi, Sara ;

Damico, Roberto ;

Conte, Pierfranco ;

Guarneri, Valentina .

NPJ BREAST CANCER, 2023, 9 (01)

[38] Azacitidine As Post-Remission Therapy in Elderly Patients with Acute Myeloid Leukemia Significantly Prolongs Disease-Free Survival: Interim Results from a Prospective, Randomized, Open-Label, Phase III Multicenter Trial [J].

Oliva, Esther Natalie ;

Alati, Caterina ;

Salutari, Prassede ;

Freyrie, Alessandra ;

Candoni, Anna ;

Simeone, Erica ;

Ventura, Giovanna ;

Cortelezzi, Agostino ;

Capelli, Debora ;

Leoni, Pietro ;

Di Bartolomeo, Paolo ;

Marino, Antonio Giovanni ;

Cufari, Patrizia ;

Di Raimondo, Francesco ;

Mauro, Elisa ;

Volpe, Antonio ;

Cascavilla, Nicola ;

Musto, Pellegrino ;

Morabito, Fortunato ;

Niscola, Pasquale ;

Specchia, Giorgina ;

Ronco, Francesca .

BLOOD, 2014, 124 (21)

[39] Progression-free survival results in postmenopausal Asian women: Subgroup analysis from a phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON) [J].

Shao, Z. ;

Ellis, M. J. ;

Robertson, J. F. R. ;

Grinsted, L. M. ;

Fazal, M. ;

Noguchi, S. .

CANCER RESEARCH, 2017, 77

[40] Mk-7264, A P2x3 Receptor Antagonist, Reduces Cough Frequency In Patients With Refractory Chronic Cough: Results From A Randomized, Controlled, Phase 2b Clinical Trial [J].

Smith, J. A. ;

Kitt, M. M. ;

Morice, A. H. ;

Birring, S. S. ;

McGarvey, L. P. ;

Sher, M. R. ;

Ford, A. P. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195

← 1 2 3 4 5 →